| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.51 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |